RT @DrNasrien: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widespread u…
RT @JACCJournals: What are best practices for using natriuretic peptides in #HeartFailure #clinicaltrials? Learn with a new #JACC position…
RT @JACCJournals: What are best practices for using natriuretic peptides in #HeartFailure #clinicaltrials? Learn with a new #JACC position…
RT @JACCJournals: What are best practices for using natriuretic peptides in #HeartFailure #clinicaltrials? Learn with a new #JACC position…
RT @JACCJournals: What are best practices for using natriuretic peptides in #HeartFailure #clinicaltrials? Learn with a new #JACC position…
RT @JACCJournals: What are best practices for using natriuretic peptides in #HeartFailure #clinicaltrials? Learn with a new #JACC position…
RT @JACCJournals: What are best practices for using natriuretic peptides in #HeartFailure #clinicaltrials? Learn with a new #JACC position…
RT @JACCJournals: What are best practices for using natriuretic peptides in #HeartFailure #clinicaltrials? Learn with a new #JACC position…
RT @JACCJournals: What are best practices for using natriuretic peptides in #HeartFailure #clinicaltrials? Learn with a new #JACC position…
The utility of #bnp #proBNP continues to be explored. I’ve typically ordered it on day of admission & discharge; I often wonder about its relative value in patients admitted with ADHF, and comorbities such as #CKD. @JACCJournals #ebm
RT @JACCJournals: What are best practices for using natriuretic peptides in #HeartFailure #clinicaltrials? Learn with a new #JACC position…
RT @JACCJournals: What are best practices for using natriuretic peptides in #HeartFailure #clinicaltrials? Learn with a new #JACC position…
RT @JACCJournals: What are best practices for using natriuretic peptides in #HeartFailure #clinicaltrials? Learn with a new #JACC position…
RT @JACCJournals: What are best practices for using natriuretic peptides in #HeartFailure #clinicaltrials? Learn with a new #JACC position…
RT @JACCJournals: What are best practices for using natriuretic peptides in #HeartFailure #clinicaltrials? Learn with a new #JACC position…
RT @JACCJournals: What are best practices for using natriuretic peptides in #HeartFailure #clinicaltrials? Learn with a new #JACC position…
RT @JACCJournals: What are best practices for using natriuretic peptides in #HeartFailure #clinicaltrials? Learn with a new #JACC position…
ตอนนี้ชีวิตวนอยู่กับอะไรซ้ำๆ จนดูรูปโมเลกุลที่เรียงกันนั้นคืออะไรแล้วอ่ะ อยากออกไปจากเรื่องพวกนี้บ้างจัง 🤓🤓🤓
RT @JACCJournals: What are best practices for using natriuretic peptides in #HeartFailure #clinicaltrials? Learn with a new #JACC position…
RT @JACCJournals: What are best practices for using natriuretic peptides in #HeartFailure #clinicaltrials? Learn with a new #JACC position…
RT @JACCJournals: What are best practices for using natriuretic peptides in #HeartFailure #clinicaltrials? Learn with a new #JACC position…
RT @JACCJournals: What are best practices for using natriuretic peptides in #HeartFailure #clinicaltrials? Learn with a new #JACC position…
RT @JACCJournals: What are best practices for using natriuretic peptides in #HeartFailure #clinicaltrials? Learn with a new #JACC position…
Outperforming the use of natriuretic peptides 💧a must need in preventing & managing HF pts 📝
RT @JACCJournals: What are best practices for using natriuretic peptides in #HeartFailure #clinicaltrials? Learn with a new #JACC position…
RT @JACCJournals: What are best practices for using natriuretic peptides in #HeartFailure #clinicaltrials? Learn with a new #JACC position…
RT @JACCJournals: What are best practices for using natriuretic peptides in #HeartFailure #clinicaltrials? Learn with a new #JACC position…
RT @JACCJournals: What are best practices for using natriuretic peptides in #HeartFailure #clinicaltrials? Learn with a new #JACC position…
What are best practices for using natriuretic peptides in #HeartFailure #clinicaltrials? Learn with a new #JACC position paper. Authors @JJheart_doc and @IAmDrIbrahim will share additional insights during this Thursday's #JACCHF Virtual Journal Club. https
【備忘】JACC HF誌に、臨床試験導入基準にBNP、NT-proBNPを用いる際の留意点を論じたポジションペーパー。 統一された基準の必要性を主張。 https://t.co/mewiJ0WUyu https://t.co/w5Kq1os7dw
Natriuretic Peptides as Inclusion Criteria in Clinical Trials | JACC: Heart Failure https://t.co/f0Ygz36xqW
Natriuretic Peptides as Inclusion Criteria in Clinical Trials https://t.co/fN4ZMn7Qqx #BNP #NTproBNP @JACCJournals @JJheart_doc @IAmDrIbrahim
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @Drlipid: BNP & NT-proBNP are used as inclusion criteria in several HF clinical trials but there is inconsistency in how BNP and NT-proB…
BNP & NT-proBNP are used as inclusion criteria in several HF clinical trials but there is inconsistency in how BNP and NT-proBNP are utilized. We really need standardized inclusion criteria across HF trials. https://t.co/KBX1aTWeGv https://t.co/AWUSqhy
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @JJheart_doc: Natriuretic peptides are frequently used as inclusion criteria for clinical trials in #HeartFailure. In this position pap…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @JJheart_doc: Natriuretic peptides are frequently used as inclusion criteria for clinical trials in #HeartFailure. In this position pap…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @JJheart_doc: Natriuretic peptides are frequently used as inclusion criteria for clinical trials in #HeartFailure. In this position pap…
RT @JJheart_doc: Natriuretic peptides are frequently used as inclusion criteria for clinical trials in #HeartFailure. In this position pap…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @JJheart_doc: Natriuretic peptides are frequently used as inclusion criteria for clinical trials in #HeartFailure. In this position pap…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @JJheart_doc: Natriuretic peptides are frequently used as inclusion criteria for clinical trials in #HeartFailure. In this position pap…
RT @JJheart_doc: Natriuretic peptides are frequently used as inclusion criteria for clinical trials in #HeartFailure. In this position pap…
Natriuretic peptides are frequently used as inclusion criteria for clinical trials in #HeartFailure. In this position paper, a team of leaders in the HF trial world discuss optimal means by which BNP/NT-proBNP might be used in this manner. Brilliant work
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
RT @IAmDrIbrahim: ♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widesprea…
♦️Our position paper on use of BNP/NT-proBNP as inclusion criteria in HF clinical trials in @JACCJournals HF ♦️Widespread use, but inconsistency in how BNP/NT-proBNP are utilized ♦️We call for standardization of NP inclusion criteria across HF trials